Accéder au contenu
Merck
Toutes les photos(1)

Documents

SML1821

Sigma-Aldrich

Imidafenacin hydrochloride

≥95% (HPLC)

Synonyme(s) :

2-Methyl-α,α-diphenyl-1H-imidazole-1-butanamide hydrochloride, 4-(2-Methyl-1-imidazolyl)-2,2-diphenylbutanamide hydrochloride, 4-(2-Methyl-1H-imidazol-1-yl)-2,2-diphenylbutanamide hydrochloride, CID 6433090 hydrochloride, HY-B06626433090 hydrochloride, KRP-197 hydrochloride, ONO-8025 hydrochloride

Se connecterpour consulter vos tarifs contractuels et ceux de votre entreprise/organisme
Toutes les photos(1)

About This Item

Formule empirique (notation de Hill):
C20H21N3O · HCl
Numéro CAS:
893421-54-0
Poids moléculaire :
355.86
Numéro MDL:
MFCD09833703
Code UNSPSC :
12352200
Nomenclature NACRES :
NA.77

Niveau de qualité

100

Pureté

≥95% (HPLC)

Forme

powder

Couleur

white to beige

Solubilité

H2O: 15 mg/mL, clear

Température de stockage

2-8°C

Actions biochimiques/physiologiques

Imidafenacin exhibits anticholinergic properties. It also has potential therapeutic effects on prostatic hyperplasia.
Imidafenacin is a potent antimuscarinic agent that exhibits selectivity toward muscarinic M3 receptors with Kb of 0.317 nM. Imidafenacin is used for treating overactive bladder.

Code de la classe de stockage

11 - Combustible Solids

Classe de danger pour l'eau (WGK)

WGK 3

Point d'éclair (°F)

Not applicable

Point d'éclair (°C)

Not applicable

Certificats d'analyse (COA)

Recherchez un Certificats d'analyse (COA) en saisissant le numéro de lot du produit. Les numéros de lot figurent sur l'étiquette du produit après les mots "Lot" ou "Batch".

Déjà en possession de ce produit ?

Retrouvez la documentation relative aux produits que vous avez récemment achetés dans la Bibliothèque de documents.

Consulter la Bibliothèque de documents

Masayuki Takeda et al.
Urology, 82(4), 887-893 (2013-08-21)
To evaluate the effects of add-on treatment with an anticholinergic (imidafenacin) on persistent overactive bladder (OAB) symptoms despite α-blocker (tamsulosin) treatment in patients with benign prostatic hyperplasia (BPH). Patients with BPH ≥50 years old, with urinary urgency at least once per
Naoki Aizawa et al.
The Journal of urology, 193(4), 1423-1432 (2014-09-16)
Imidafenacin and fesoterodine are used to treat overactive bladder. Imidafenacin, fesoterodine and its active metabolite 5-hydroxymethyl tolterodine are muscarinic receptor antagonists. It is believed that these agents act on afferent nerves in addition to smooth muscle. We investigated the effects
Kuanglei Wang et al.
Bioorganic chemistry, 98, 103757-103757 (2020-03-29)
Carbamyl is considered a privileged structure in medicinal chemistry. It has a wide range of biological activities such as antimicrobial, anticancer, anti-epilepsy, for which the best evidence is a number of marketed carbamyl-containing drugs. Carbamyl is formed of primary amine
Takanobu Yamazaki et al.
European journal of pharmacology, 791, 72-77 (2016-10-30)
Imidafenacin, an antimuscarinic agent for treating overactive bladder, has an antidiuretic effect, but the detailed mechanisms of action remain unclear. The cholinergic and vasopressin systems are known to interact, for example, in the suppression of vasopressin-induced water reabsorption through muscarinic
Shiori Kuraoka et al.
Journal of pharmacological sciences, 131(3), 184-189 (2016-07-20)
The present study aimed to directly characterize specific binding sites of tritium ([(3)H])-labeled imidafenacin, a new radioligand for labeling muscarinic receptors, in the bladder and other peripheral or central nervous tissues of rats. Muscarinic receptors in rat tissues were measured

Notre équipe de scientifiques dispose d'une expérience dans tous les secteurs de la recherche, notamment en sciences de la vie, science des matériaux, synthèse chimique, chromatographie, analyse et dans de nombreux autres domaines..

Contacter notre Service technique